Magnetic Field-Induced T Cell Receptor Clustering by Nanoparticles Enhances T Cell Activation and Stimulates Antitumor Activity
Source abstract
Abstract
Iron-dextran nanoparticles functionalized with T cell activating proteins have been used to study T cell receptor (TCR) signaling. However, nanoparticle triggering of membrane receptors is poorly understood and may be sensitive to physiologically regulated changes in TCR clustering that occur after T cell activation. Nano-aAPC bound 2-fold more TCR on activated T cells, which have clustered TCR, than on naive T cells, resulting in a lower threshold for activation. To enhance T cell activation, a magnetic field was used to drive aggregation of paramagnetic nano-aAPC, resulting in a doubling of TCR cluster size and increased T cell expansion in vitro and after adoptive transfer in vivo. T cells activated by nano-aAPC in a magnetic field inhibited growth of B16 melanoma, showing that this novel approach, using magnetic field-enhanced nano-aAPC stimulation, can generate large numbers of activated antigen-specific T cells and has clinically relevant applications for adoptive immunotherapy.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Immunotherapy and Immune Responses · CAR-T cell therapy research · Immune Cell Function and Interaction
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Miltenyi Biotec, Bergisch Gladbach, Germany
Funding
National Cancer Institute
References (46)
Show source-provided references
1. Fay F. · Immunotherapy · 2011 · 3 · 38110.2217/imt.11.5 ↗
2. Moon J. J. · Adv. Mater. · 2012 · 24 · 372410.1002/adma.201200446 ↗
3. Perica K. · Nanomedicine · 2013 · 10 · 11910.1016/j.nano.2013.06.015 ↗
4. Luxembourg A. T. · J. Immunol. · 1998 · 161 · 522610.4049/jimmunol.161.10.5226 ↗
5. Rogers J. · J. Immunol. · 1992 · 149 · 26910.4049/jimmunol.149.1.269 ↗
6. Motta I. · Eur. J. Immunol. · 1998 · 28 · 368510.1002/(SICI)1521-4141(199811)28:11<3685::AID-IMMU3685>3.0.CO;2-3 ↗
7. Van der Merwe P. A. · Nat. Rev. Immunol. · 2010 · 11 · 4710.1038/nri2887 ↗
8. Oelke M. · Nat. Med. · 2003 · 9 · 61910.1038/nm869 ↗
9. Ugel S. · Cancer Res. · 2009 · 69 · 937610.1158/0008-5472.CAN-09-0400 ↗
10. Oelke M. · Immunol. Res. · 2010 · 47 · 24810.1007/s12026-009-8156-z ↗
11. Steenblock E. · Expert Opin. Biol. Ther. · 2009 · 9 · 45110.1517/14712590902849216 ↗
12. Nel A. E. · Nat. Mater. · 2009 · 8 · 54310.1038/nmat2442 ↗
13. Fahmy T. M. · Immunity · 2001 · 14 · 135
14. Kumar R. · Immunity · 2011 · 35 · 37510.1016/j.immuni.2011.08.010 ↗
15. Boyle S. · Biophys. J. · 2011 · 101 · L5710.1016/j.bpj.2011.10.028 ↗
16. Perica K. · Biophys. J. · 2012 · 103 · 189010.1016/j.bpj.2012.09.011 ↗
17. Lillemeier B. F. · Nat. Immunol. · 2010 · 11 · 9010.1038/ni.1832 ↗
18. Varma R. · Immunity · 2006 · 25 · 11710.1016/j.immuni.2006.04.010 ↗
19. Lee J.-H. · Angew. Chem., Int. Ed. · 2010 · 49 · 569810.1002/anie.201001149 ↗
20. Mannix R. J. · Nat. Nanotechnol. · 2008 · 3 · 3610.1038/nnano.2007.418 ↗
21. Cho M. H. · Nat. Mater. · 2012 · 11 · 103810.1038/nmat3430 ↗
22. Smith-Garvin J. E. · Annu. Rev. Immunol. · 2009 · 27 · 59110.1146/annurev.immunol.021908.132706 ↗
23. Kunzmann A. · Biochim. Biophys. Acta · 2010 · 1810 · 36110.1016/j.bbagen.2010.04.007 ↗
24. Turtle C. J. · Cancer J. · 2010 · 16 · 37410.1097/PPO.0b013e3181eb33a6 ↗
25. Gunn J. · Small · 2008 · 4 · 71210.1002/smll.200701103 ↗
26. Fahmy T. M. · J. Immunol. Methods · 2002 · 268 · 9310.1016/S0022-1759(02)00203-X ↗
27. Dobson J. · Nat. Nanotechnol. · 2008 · 3 · 13910.1038/nnano.2008.39 ↗
28. James J. R. · Nature · 2012 · 487 · 6410.1038/nature11220 ↗
29. Hughes S. · Med. Eng. Phys. · 2005 · 27 · 75410.1016/j.medengphy.2005.04.006 ↗
30. Lim T. S. · J. Immunol. · 2011 · 187 · 25810.4049/jimmunol.1100267 ↗
31. Husson J. · PLoS One · 2011 · 6 · e1968010.1371/journal.pone.0019680 ↗
32. Jenkins M. K. · J. Immunol. · 2012 · 188 · 413510.4049/jimmunol.1102661 ↗
33. Blattman J. N. · J. Exp. Med. · 2002 · 195 · 65710.1084/jem.20001021 ↗
34. Klebanoff C. A. · Clin. Cancer Res. · 2011 · 17 · 534310.1158/1078-0432.CCR-11-0503 ↗
35. Wrzesinski C. · J. Immunother. · 2010 · 33 · 110.1097/CJI.0b013e3181b88ffc ↗
36. Restifo N. P. · Nat. Rev. Immunol. · 2012 · 12 · 26910.1038/nri3191 ↗
37. Naahidi S. · J. Controlled Release · 2013 · 166 · 18210.1016/j.jconrel.2012.12.013 ↗
38. Grützkau A. · Cytometry A · 2010 · 77 · 64310.1002/cyto.a.20918 ↗
39. Dvorak C. C. · Bone Marrow Transplant · 2013 · 48 · 50810.1038/bmt.2012.186 ↗
40. Cheng K. · Cell Transplant. · 2012 · 21 · 112110.3727/096368911X627381 ↗
41. Kobayashi T. · Arthroscopy · 2008 · 24 · 6910.1016/j.arthro.2007.08.017 ↗
42. Arbab A. S. · Hum. Gene Ther. · 2004 · 15 · 35110.1089/104303404322959506 ↗
43. Hinrichs C. S. · Blood · 2011 · 117 · 80810.1182/blood-2010-05-286286 ↗
44. Hinrichs C. S. · Proc. Natl. Acad. Sci. U.S.A. · 2009 · 106 · 1746910.1073/pnas.0907448106 ↗
45. Klebanoff C. A. · J. Immunother. · 2012 · 35 · 65110.1097/CJI.0b013e31827806e6 ↗
46. Durai M. · Cancer Immunol. Immunother. · 2009 · 58 · 20910.1007/s00262-008-0542-1 ↗